🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
The purpose of this study is to evaluate safety and immunogenicity of Pedia...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00343421
Treatments Being Tested
Currently, there is no 5-component acellular pertussis vaccine licensed for...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00467519
Primary objectives: * To assess the safety profile of each SP0202 formulat...
Status
Completed
Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Start Date
2020-05-22
Trial ID
NCT04398706
Treatments Being Tested
This phase IV trial investigates whether one dose of a human papillomavirus...
Status
Active Not Recruiting
Location
Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Start Date
2017-11-29
Trial ID
NCT03180034
The objective for this study is to characterize the safety profile of PENTA...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00804284
Treatments Being Tested
This is a randomized, blinded, controlled phase II and III clinical trial e...
Status
Completed
Location
Kaihua County Center for Disease Control and Prevention
Start Date
2024-12-20
Trial ID
NCT06708286
This study was designed to assess the lot comparability of DAPTACEL, as wel...
Status
Completed
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT00662870
This study is designed to assess the immunogenicity and safety of DTaP vacc...
Status
Completed
Location
Investigational site
Start Date
2014-04
Trial ID
NCT02118961
This phase IV trial tests whether a single dose of the human papillomavirus...
Status
Active Not Recruiting
Location
Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Start Date
2022-03-01
Trial ID
NCT05237947